Decide what you are willing to monitor: bloodwork, training logs, body comp
Thus, this simple metabolic observation provides a new means for both i) CSC identification [913] and ii) CSC eradication [9, 10, 1419]
Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE
And this often is a form factor as you outlined or it could be dosing dynamics of a patient is not getting the outcome that theyre hoping for, are they experiencing side effects that are intolerable
van Royen M, Carb N, Busquets S, Alvarez B, Quinn LS, Lpez-Soriano FJ, et al
As a GLP-1 receptor agonist, semaglutide is typically well-tolerated and offers a reliable option to help patients reduce appetite, lower calorie intake, and achieve gradual, sustainable weight loss